Cardax, Inc. logo

Cardax, Inc.

Cardax is developing orally bioavailable anti-inflammatory compounds with robust safety for major unmet medical needs.

17 employees · est. 2006 · Honolulu, United States

VS
Iroko Pharmaceuticals, LLC logo

Iroko Pharmaceuticals, LLC

42 employees · est. 2007 · Philadelphia, United States

Cardax, Inc. is the older company (2006 vs 2007).

Side-by-Side Comparison

Cardax, Inc. Iroko Pharmaceuticals, LLC
Founded
2006 older 2007
Headquarters
Honolulu, United States Philadelphia, United States
Employees
17 42
Industry
Biopharma, Biotechnology, Health Care Biotechnology, Life Sciences, Pharmaceutical
Funding Stage
Post Ipo Equity Debt Financing
Total Funding
Not tracked yet $215.00M
Funding Rounds
9 2
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Life Sciences, Pharmaceuticals, Nutraceuticals, Anti-inflammatory Compounds, Oxidative Stress, Astaxanthin Therapies, Metabolic Disease, Cardiovascular Disease, Rheumatoid Arthritis, Dyslipidemia, Osteoarthritis, Cognitive Decline, Macular Degeneration, Prostate Disease, Small Molecule Therapies Pharmaceuticals, Analgesia, NSAIDs, Drug Development, Pain Management, SoluMatrix Fine Particle Technology, Global Presence, Innovation, Nano-formulated Drugs, Prescription Medicines, Distribution Network, Sales Network, New Technology
Website
cardaxpharma.com iroko.com
Cardax, Inc. logo

About Cardax, Inc.

Cardax, Inc. is a US-based company, founded in 2006, specializing in the development of orally bioavailable anti-inflammatory compounds to address major unmet medical needs. The company focuses on creating proprietary astaxanthin therapies for conditions in which oxidative stress and inflammation pl...

Iroko Pharmaceuticals, LLC logo

About Iroko Pharmaceuticals, LLC

Iroko Pharmaceuticals, LLC is a biotechnology and pharmaceutical company founded in 2007 in the United States. The company is dedicated to advancing the science of analgesia, aiming to offer new options for responsible pain management. Iroko uses innovative proprietary SoluMatrix Fine Particle Techn...

We will tell you when either one moves

BounceWatch watches Cardax, Inc. and Iroko Pharmaceuticals, LLC for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Cardax, Inc. and Iroko Pharmaceuticals,... — by email.

Frequently Asked Questions

Cardax, Inc. — Cardax is developing orally bioavailable anti-inflammatory compounds with robust safety for major unmet medical needs.. Iroko Pharmaceuticals, LLC. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Cardax, Inc. has raised undisclosed funding while Iroko Pharmaceuticals, LLC has raised $215.00M.
Cardax, Inc. and Iroko Pharmaceuticals, LLC operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Cardax, Inc. with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Cardax, Inc. on 18 Nov 2024, and Iroko Pharmaceuticals, LLC on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes